Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
UTHR
Stock Latest News
The Fly
United Therapeutics management to meet with Oppenheimer
24d ago
UTHR
Premium
The Fly
United Therapeutics price target raised to $600 from $580 at UBS
2M ago
UTHR
Premium
The Fly
United Therapeutics announces first clinical xenotransplantation in EXPAND study
2M ago
UTHR
Premium
The Fly
United Therapeutics price target raised to $587 from $569 at RBC Capital
2M ago
UTHR
Premium
The Fly
United Therapeutics price target raised to $525 from $500 at H.C. Wainwright
2M ago
UTHR
Premium
The Fly
United Therapeutics price target raised to $447 from $435 at Morgan Stanley
2M ago
UTHR
Premium
Ratings
United Therapeutics: Hold Rating Amid Optimistic Partnership Prospects and Adjusted Revenue Goals
2M ago
UTHR
Premium
Company Announcements
United Therapeutics Reports Record Q3 2025 Results
2M ago
UTHR
Premium
Company Announcements
United Therapeutics Corp’s Earnings Call Highlights Growth and Innovation
2M ago
UTHR
Premium
Ratings
Strong Growth Potential and Strategic Initiatives Drive Buy Rating for United Therapeutics
2M ago
UTHR
Premium
The Fly
United Therapeutics price target raised to $575 from $564 at Jefferies
2M ago
UTHR
Premium
Ratings
United Therapeutics: Strong Growth Potential Amid Short-Term Volatility Supports Buy Rating
2M ago
UTHR
Premium
The Fly
Morning Movers: Nvidia jumps after GTC, Trump comments
2M ago
BA
FI
Premium
The Fly
United Therapeutics reports Q3 EPS $7.16, consensus $6.96
2M ago
UTHR
Premium
The Fly
Notable companies reporting before tomorrow’s open
2M ago
BA
FI
Premium
Company Announcements
United Therapeutics’ Promising Study on Inhaled Treprostinil for Lung Disease
2M ago
UTHR
Premium
Company Announcements
United Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis
2M ago
UTHR
Premium
Company Announcements
United Therapeutics’ AI-Driven Study: A Potential Game-Changer for Pulmonary Hypertension Diagnosis
2M ago
UTHR
Premium
Company Announcements
United Therapeutics’ DeciPHer-ILD Study: A Closer Look at PH-ILD Patient Registry
2M ago
UTHR
Premium
Company Announcements
United Therapeutics’ Xenokidney Study: A New Hope for ESRD Patients
2M ago
UTHR
Premium
Company Announcements
United Therapeutics’ PHINDER Study: A Step Forward in Early Detection of Pulmonary Hypertension
2M ago
UTHR
Premium
Company Announcements
United Therapeutics Advances Ralinepag Study for PAH Treatment
2M ago
UTHR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.